Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
43.68 USD | -4.15% |
|
-10.09% | +7.16% |
06-07 | Structure Therapeutics Closes $547.4 Million Offering | MT |
06-07 | BMO Capital Adjusts Price Target on Structure Therapeutics to $100 From $83, Maintains Outperform Rating | MT |
Chart calendar Structure Therapeutics Inc.
Upcoming events on Structure Therapeutics Inc.
Past events on Structure Therapeutics Inc.
03/06/2024 13:30 | GSBR-1290 Phase 2a Study Results Call |
09/05/2024 21:05 | Q1 2024 Earnings Release |
13/03/2024 12:00 | Leerink Partners Global Biopharma Conference |
08/03/2024 13:30 | Q4 2023 Earnings Release |
18/12/2023 13:30 | Business Update Call |
14/11/2023 21:10 | Q3 2023 Earnings Release |
29/09/2023 13:30 | Business Update Call |
10/08/2023 21:05 | Q2 2023 Earnings Release |
25/06/2023 19:30 | American Diabetes Association Scientific Session - Poster No - 760 |
25/06/2023 19:30 | American Diabetes Association Scientific Meeting - Poster No - 754 |
08/06/2023 14:30 | Jefferies Global Healthcare Conference |
24/05/2023 17:00 | American Thoracic Society International Conference - Poster No: P925 |
22/05/2023 16:30 | American Thoracic Society International Conference - Poster No: P207 |
21/05/2023 16:30 | American Thoracic Society International Conference - Poster No: P1059 |
11/05/2023 21:30 | Q1 2023 Earnings Release |
30/03/2023 21:30 | Q4 2022 Earnings Release |
Annual results
Fiscal Period | December | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
EBITDA Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | -162 |
EBIT Million USD | Released Forecast Spread | 0,00 | -52,6 -52,6 0.07% | -103 -101 -1.33% | -156 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -51,3 -52,1 1.53% | -89,4 -91,7 2.52% | -145 |
Net income Million USD | Released Forecast Spread | -38,0 | -52,8 -52,4 -0.83% | -89,6 -93,4 4.01% | -132 |
EPS USD | Released Forecast Spread | -5,38 | -5,51 -4,94 -11.54% | -0,81 -0,87 7.32% | -0,92 |
Announcement Date | 12/01/23 | 30/03/23 | 08/03/24 | - |
Quarterly results
Fiscal Period | December | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
EBITDA Million USD | Released Forecast Spread | -32,0 | -47,0 | -52,0 | ||||||||
EBIT Million USD | Released Forecast Spread | -13,0 -13,0 0.34% | -19,6 -17,7 -11.33% | -26,0 -20,3 -27.73% | -26,1 -26,8 2.38% | -31,0 -26,9 -15.2% | -32,0 -37,0 13.36% | -35,9 | -41,6 | -50,7 | -40,8 | -43,4 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -12,1 -12,9 6.55% | -18,0 -16,2 -10.8% | -23,2 -20,0 -15.84% | -23,5 -27,0 13.04% | -24,8 -26,9 7.76% | -26,0 -28,4 8.53% | -33,0 | -39,3 | -44,1 | -40,8 | -43,4 |
Net income Million USD | Released Forecast Spread | -11,9 -13,0 8.65% | -18,0 -16,6 -8.28% | -23,3 -19,0 -22.55% | -23,9 -27,0 11.57% | -24,5 -27,4 10.66% | -26,0 -29,0 10.1% | -32,2 | -36,8 | -40,9 | -40,8 | -43,4 |
EPS USD | Released Forecast Spread | -1,17 -1,10 -6.36% | -0,25 -0,34 25.37% | -0,20 -0,20 0% | -0,21 -0,24 11.27% | -0,16 -0,21 22.89% | -0,19 -0,21 9.52% | -0,23 | -0,24 | -0,26 | -0,26 | -0,29 |
Announcement Date | 30/03/23 | 11/05/23 | 10/08/23 | 14/11/23 | 08/03/24 | 09/05/24 | - | - | - | - | - |
Past sector events for Structure Therapeutics Inc.
05/06/2024 08:51 | PHARMAESSENTIA CORPORATION: May 2024 Sales and Revenue Release |
17/05/2024 12:00 | AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release |
16/05/2024 12:46 | BIOCON LIMITED: Q4 2024 Earnings Release |
16/05/2024 06:00 | ZEALAND PHARMA A/S: Q1 2024 Earnings Release |
15/05/2024 | LIGACHEM BIOSCIENCES INC.: Q1 2024 Earnings Release |
15/05/2024 13:05 | THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release |
15/05/2024 12:00 | CABALETTA BIO, INC.: Q1 2024 Earnings Release |
14/05/2024 | TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release |
14/05/2024 21:05 | ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
14/05/2024 21:00 | ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- GPCR Stock
- Calendar Structure Therapeutics Inc.